"The U.S. Food and Drug Administration today approved the Gastric Emptying Breath Test (GEBT), a new non-invasive test to aid in the diagnosis of delayed gastric emptying, known as gastroparesis.
Current tests used to diagnose gastroparesis "...
VIOKASE® (pancrelipase tablets, powder) should not be held in the mouth as the proteolytic action may cause irritation of the mucosa.
Avoid inhalation of the powder when administering VIOKASE® (pancrelipase tablets, powder) .
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Last reviewed on RxList: 12/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Viokase Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.